Modalis Therapeutics (4883.TSE) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-15
-13
-12
-10

Details

Expected EPS
N/A
Actual EPS
-14
Surprise EPS
-14
Surprise Percent
+∞%

Description

Modalis Therapeutics (4883.TSE) has reported earnings of -14 per share for Q2 2024.

0 Comments

Share your thoughts